Download the Drug Discovery Insights to learn more about our Neurodegenerative Diseases collaboration with Celgene. Read about why we are utilizing iPSC-based disease models, meet the team behind the collaboration, and learn how our iPSC accelerator platform is combining technologies for further success.
